• Cat-intel
  • MedIntelliX
  • Resources
  • About Us
  • Request Free Sample ×

    Kindly complete the form below to receive a free sample of this Report

    Leading companies partner with us for data-driven Insights

    clients tt-cursor

    China Monoclonal Antibody Custom Service Market

    ID: MRFR/HC/51234-HCR
    200 Pages
    Garvit Vyas
    September 2025

    China Monoclonal Antibody Custom Service Market Research Report By Type (Rat Custom Monoclonal Antibody, Rabbit Custom Monoclonal Antibody), By Application (Diagnostic Application (Biochemical Analysis (Pregnancy Cancer Hormonal Disorder And Infectious Diseases), Diagnostic Imaging (Cardiovascular Diseases, Cancer and Bacterial Infections), Therapeutic Application (MAb as Therapeutic Agents and MAb as Targeting Agents), Protein Purification) and By End User (Hospitals, Research)- Forecast to 2035

    Share:
    Download PDF ×

    We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

    China Monoclonal Antibody Custom Service Market Research Report -Forecast to 2035 Infographic
    Purchase Options
    $ 4,950.0
    $ 5,950.0
    $ 7,250.0
    Table of Contents

    China Monoclonal Antibody Custom Service Market Summary

    The China Monoclonal Antibody Custom Service market is poised for substantial growth, reaching 286.5 million USD by 2035.

    Key Market Trends & Highlights

    China Monoclonal Antibody Custom Service Key Trends and Highlights

    • The market is valued at 54.6 million USD in 2024, indicating a strong starting point for growth.
    • From 2025 to 2035, the market is expected to grow at a compound annual growth rate of 16.26 percent.
    • By 2035, the market is projected to expand to 286.5 million USD, reflecting increasing demand.
    • Growing adoption of monoclonal antibodies due to advancements in biotechnology is a major market driver.

    Market Size & Forecast

    2024 Market Size 54.6 (USD Million)
    2035 Market Size 286.5 (USD Million)
    CAGR (2025-2035) 16.26%

    Major Players

    Tigermed, Abcam, BioRad, Genscript, MedChemExpress, Novoprotein, GenScript Biotech, Sino Biological, WuXi AppTec, HengRui Medicine, Thermo Fisher Scientific, Cell Signaling Technology, KeyGen Biotech, Fapon Biotech, Eureka Therapeutics

    China Monoclonal Antibody Custom Service Market Trends

    The China monoclonal antibody custom service market has some prominent trends that shape it. One of the fundamental factors is the increase in funding from both the private and public sectors into biotechnology and pharmaceutical research. The government of China still continues to support the development of biotechnology with the aim of establishing the country as the world’s powerhouse in that field. This is very much evident through policies and initiatives which enable partnerships between businesses and research institutions to foster monoclonal antibody innovation.

    The market is also expanding because of the increasing prevalence of some chronic diseases like cancer and autoimmune diseases.

    While heading towards precision medicine, the healthcare system in China is aimed at monoclonal antibodies for targeted therapies. This development provides opportunities for tailored solutions aimed at specific clinical requirements. Recently, there has been greater attention towards regulatory compliance and quality standards in the marketplace. With China's expansion to international healthcare norms, custom monoclonal antibody services providers are improving their workflows to fully conform with domestic and global standards. This issue is important for competitive market positioning as adherence to quality benchmarks is fundamental in clinching customer confidence and market entry.

    Furthermore, the custom service market is witnessing the beginning of digital transformation. This encompasses the application of AI and data analytics for optimizing workflows, lowering costs, and enhancing turnaround times. These advancements in technology will improve operational productivity and also add a differentiation factor to manufacturers seeking to expand their presence in China and outside China. In any case, these interlinked trends will transform the China Monoclonal Antibody Custom Service Market, improving patient care and growing the industry.

    China Monoclonal Antibody Custom Service Market Drivers

    Market Segment Insights

    Monoclonal Antibody Custom Service Market Type Insights

    The China Monoclonal Antibody Custom Service Market has been categorized into various types, with Rat Custom Monoclonal Antibody and Rabbit Custom Monoclonal Antibody emerging as significant categories. These types have gained prominence in the market due to their unique properties and applications in research and development. Rat Custom Monoclonal Antibodies are favored for their cost-effectiveness and rapid generation process, making them ideal for various preclinical studies.

    Their immunological responses are well understood, allowing for precise targeting in research initiatives.Conversely, Rabbit Custom Monoclonal Antibodies are renowned for their ability to recognize a broad range of antigens with high affinity and specificity, which is particularly valued in complex applications such as biomarker discovery and therapeutic development. The growing demand for these antibody types reflects the rapid advancements in the biotechnology and pharmaceutical sectors within China, as organizations are continually seeking reliable and efficient antibody solutions for immunoassays, diagnostics, and therapeutic uses.

    The ability to customize these antibodies further enhances their appeal, allowing researchers to meet specific study requirements effectively.With China's increasing investment in biomedical research and its commitment to innovation, both Rat and Rabbit Custom Monoclonal Antibodies are likely to play pivotal roles in advancing biomedical applications, contributing to the overall growth of the China Monoclonal Antibody Custom Service Market. The competitive landscape is further bolstered by advancements in antibody generation technologies and the integration of AI and automation, which streamline the production processes and reduce lead times, ultimately fostering market growth.

    Monoclonal Antibody Custom Service Market Application Insights

    The Application segment of the China Monoclonal Antibody Custom Service Market plays a critical role in advancing healthcare outcomes across various fields. In the realm of Diagnostic Application, Biochemical Analysis serves as a key driver, particularly in areas such as pregnancy, cancer, hormonal disorders, and infectious diseases. This aspect not only facilitates early detection but is also crucial for effective treatment planning. Furthermore, Diagnostic Imaging significantly contributes to the identification of cardiovascular diseases, cancers, and bacterial infections, thereby improving patient management strategies and outcomes.

    The Therapeutic Application encompasses the use of monoclonal antibodies both as therapeutic agents and targeting agents, emphasizing their utility in treating complex conditions with precision and minimal side effects. Moreover, Protein Purification stands out as a vital process for obtaining high-quality monoclonal antibodies, which ultimately supports research and development efforts in both diagnostics and therapeutics. Collectively, these areas reflect the pivotal role of the Application segment in the China Monoclonal Antibody Custom Service Market, addressing unmet medical needs while offering opportunities for innovation and growth in the healthcare landscape.

    Monoclonal Antibody Custom Service Market End User Insights

    The End User segment of the China Monoclonal Antibody Custom Service Market plays a crucial role in healthcare and scientific research, reflecting diverse needs in applications. Hospitals are essential clients in this segment, utilizing monoclonal antibodies for diagnostics and therapeutics, enhancing patient care through targeted treatments. Research entities rely on these services to develop innovative therapies and understand disease mechanisms better, leading to breakthroughs in medicine. Hospital-based laboratories are increasingly adopting this technology as they emphasize personalized medicine.

    Conversely, the Research and Development sector continually seeks advancements in monoclonal antibody technology for drug discovery, accelerating developments in oncology and immunology. The growing number of health initiatives and government support for biotechnology in China propels this segment further, indicating increased investment in monoclonal antibodies. Overall, the significance of the End User segment lies in its ability to drive forward both patient outcomes and scientific discovery within the country’s rapidly evolving healthcare landscape.

    Get more detailed insights about China Monoclonal Antibody Custom Service Market Research Report -Forecast to 2035

    Regional Insights

    Key Players and Competitive Insights

    The China Monoclonal Antibody Custom Service Market has gained traction as a vital platform for researchers, healthcare professionals, and biotechnology firms seeking cutting-edge solutions in therapeutic development and diagnostics. This market is characterized by emerging players and established companies vying for a share in an increasingly competitive landscape. The focus on custom antibody development underlines the importance of personalized medicine and targeted therapies, driving innovation and investment into the sector. Companies within this market are enhancing their offerings through advanced technologies and methodologies, aiming to cater to a broad spectrum of demands spanning from academic research to commercial applications.

    With the growing healthcare expenditure in China and increasing investments in biotechnology, the market is poised for significant growth, making it essential for companies to understand their competitive positioning.Tigermed has secured a notable presence in the China Monoclonal Antibody Custom Service Market, renowned for its comprehensive range of services tailored specifically for the development of therapeutic antibodies. The company boasts a strong foundation built on scientific expertise and innovative solutions, enabling it to address the diverse needs of clients from various sectors, including pharmaceuticals and research institutions.

    With a focus on quality assurance and regulatory compliance, Tigermed stands out for its robust project management capabilities and extensive experience in navigating complex clinical landscapes within China. This allows them to streamline processes and facilitate the successful development and commercialization of monoclonal antibodies, contributing to their reputation as a trusted partner in custom services.Abcam has cultivated a significant market presence in the China Monoclonal Antibody Custom Service Market through its dedication to providing high-quality reagents and extensive custom services for research and clinical applications.

    The company is known for its innovative product offerings, including monoclonal antibodies that cater to various scientific disciplines and therapeutic areas.

    Abcam's strengths lie in its commitment to research excellence and customer satisfaction, supported by a well-established network that enhances its outreach across China. Recent strategic initiatives, including collaborations and mergers with local firms, have further solidified their market standing. With a reputation for reliability and superior technical support, Abcam continues to enhance its service capabilities and product portfolio tailored for the Chinese market, thereby reinforcing its competitive edge in the monoclonal antibody landscape.

    Key Companies in the China Monoclonal Antibody Custom Service Market market include

    Industry Developments

    Recent developments in the China Monoclonal Antibody Custom Service Market have seen significant growth, driven by advancements in biotechnology and a rising demand for monoclonal antibodies in therapeutic and diagnostic applications. Companies such as Tigermed, Abcam, BioRad, and GenScript are expanding their services, enhanced by increased investment in Research and Development. In July 2023, WuXi AppTec announced an increase in its manufacturing capabilities, allowing for greater production of custom monoclonal antibodies to meet the expanding market demand.

    Furthermore, Sino Biological reported a strategic collaboration with Novoprotein in April 2023 to combine resources for developing specialized antibody services. In terms of market valuation, recent reports indicate that the total market size for monoclonal antibody services in China is projected to reach $XX billion by 2025, reflecting a compound annual growth rate attributed to the rise in healthcare expenditure from the government’s initiatives promoting biopharmaceutical innovation. Notably, HengRui Medicine is also strengthening its position in the market landscape through targeted acquisitions that emphasize their custom services.

    These trends indicate a robust competitive landscape fueled by innovations and collaborations among these leading firms in China's monoclonal antibody sector.

    Market Segmentation

    Monoclonal Antibody Custom Service Market Type Outlook

    • Rat Custom Monoclonal Antibody
    • Rabbit Custom Monoclonal Antibody

    Monoclonal Antibody Custom Service Market End User Outlook

    • Hospitals
    • Research

    Monoclonal Antibody Custom Service Market Application Outlook

    • Diagnostic Application (Biochemical Analysis (Pregnancy Cancer Hormonal Disorder And Infectious Diseases))
    • Diagnostic Imaging (Cardiovascular Diseases, Cancer and Bacterial Infections)
    • Therapeutic Application (MAb as Therapeutic Agents and MAb as Targeting Agents)
    • Protein Purification

    Report Scope

    Report Attribute/Metric Source: Details
    MARKET SIZE 2018 51.8(USD Million)
    MARKET SIZE 2024 54.6(USD Million)
    MARKET SIZE 2035 286.5(USD Million)
    COMPOUND ANNUAL GROWTH RATE (CAGR) 16.265% (2025 - 2035)
    REPORT COVERAGE Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
    BASE YEAR 2024
    MARKET FORECAST PERIOD 2025 - 2035
    HISTORICAL DATA 2019 - 2024
    MARKET FORECAST UNITS USD Million
    KEY COMPANIES PROFILED Tigermed, Abcam, BioRad, Genscript, MedChemExpress, Novoprotein, GenScript Biotech, Sino Biological, WuXi AppTec, HengRui Medicine, Thermo Fisher Scientific, Cell Signaling Technology, KeyGen Biotech, Fapon Biotech, Eureka Therapeutics
    SEGMENTS COVERED Type, Application, End User
    KEY MARKET OPPORTUNITIES Growing biopharmaceutical research demand, Rapid advancements in genomics, Increasing prevalence of chronic diseases, Expanding healthcare budget and investment, Collaborative partnerships with universities and institutes
    KEY MARKET DYNAMICS Rising demand for personalized medicine, Increased investment in R&D, Regulatory challenges and compliance, Growth of biopharmaceutical industry, Advancements in antibody engineering technologies
    COUNTRIES COVERED China

    Market Highlights

    Author
    Garvit Vyas
    Analyst

    Explore the profile of Garvit Vyas, one of our esteemed authors at Market Research Future, and access their expert research contributions in the field of market research and industry analysis

    Leave a Comment

    FAQs

    What is the expected market size of the China Monoclonal Antibody Custom Service Market in 2024?

    The China Monoclonal Antibody Custom Service Market is expected to be valued at 54.6 USD Million in 2024.

    What is the projected market size for the China Monoclonal Antibody Custom Service Market by 2035?

    By 2035, the market size is projected to grow to 286.5 USD Million.

    What is the expected CAGR for the China Monoclonal Antibody Custom Service Market between 2025 and 2035?

    The expected CAGR for the market during 2025 to 2035 is 16.265%.

    Which type of monoclonal antibodies dominates the market share in 2024?

    In 2024, Rabbit Custom Monoclonal Antibodies are expected to have a market value of 32.1 USD Million.

    What will be the market value for Rat Custom Monoclonal Antibodies in 2035?

    The market value for Rat Custom Monoclonal Antibodies is projected to reach 112.5 USD Million by 2035.

    Who are some of the major players in the China Monoclonal Antibody Custom Service Market?

    Major players in the market include Tigermed, Abcam, BioRad, Genscript, and MedChemExpress.

    What growth opportunities exist in the China Monoclonal Antibody Custom Service Market?

    The market offers growth opportunities driven by advancements in biotechnology and increasing research funding.

    What are some key applications of monoclonal antibodies in China?

    Key applications include therapeutic development, diagnostics, and research purposes in various diseases.

    How does the market growth rate vary between different types of monoclonal antibodies?

    The market growth rate for different monoclonal antibody types is influenced by specific applications and therapeutic needs.

    What is the impact of current global trends on the China Monoclonal Antibody Custom Service Market?

    Current global trends, including increased biomedical research and personalized medicine, positively influence market growth.

    1. EXECUTIVE
    2. SUMMARY
    3. Market Overview
    4. Key Findings
    5. Market Segmentation
    6. Competitive Landscape
    7. Challenges and Opportunities
    8. Future Outlook
    9. MARKET INTRODUCTION
    10. Definition
    11. Scope of the study
    12. Research Objective
    13. Assumption
    14. Limitations
    15. RESEARCH
    16. METHODOLOGY
    17. Overview
    18. Data
    19. Mining
    20. Secondary Research
    21. Primary
    22. Research
    23. Primary Interviews and Information Gathering
    24. Process
    25. Breakdown of Primary Respondents
    26. Forecasting
    27. Model
    28. Market Size Estimation
    29. Bottom-Up
    30. Approach
    31. Top-Down Approach
    32. Data
    33. Triangulation
    34. Validation
    35. MARKET
    36. DYNAMICS
    37. Overview
    38. Drivers
    39. Restraints
    40. Opportunities
    41. MARKET FACTOR ANALYSIS
    42. Value chain Analysis
    43. Porter's
    44. Five Forces Analysis
    45. Bargaining Power of Suppliers
    46. Bargaining
    47. Power of Buyers
    48. Threat of New Entrants
    49. Threat
    50. of Substitutes
    51. Intensity of Rivalry
    52. COVID-19
    53. Impact Analysis
    54. Market Impact Analysis
    55. Regional
    56. Impact
    57. Opportunity and Threat Analysis
    58. China
    59. Monoclonal Antibody Custom Service Market, BY Type (USD Million)
    60. Rat
    61. Custom Monoclonal Antibody
    62. Rabbit Custom Monoclonal Antibody
    63. China
    64. Monoclonal Antibody Custom Service Market, BY Application (USD Million)
    65. Diagnostic
    66. Application (Biochemical Analysis (Pregnancy Cancer Hormonal Disorder And Infectious
    67. Diseases)
    68. Diagnostic Imaging (Cardiovascular Diseases,
    69. Cancer and Bacterial Infections)
    70. Therapeutic Application
    71. (MAb as Therapeutic Agents and MAb as Targeting Agents)
    72. Protein
    73. Purification
    74. China Monoclonal
    75. Antibody Custom Service Market, BY End User (USD Million)
    76. Hospitals
    77. Research
    78. Competitive Landscape
    79. Overview
    80. Competitive
    81. Analysis
    82. Market share Analysis
    83. Major
    84. Growth Strategy in the Monoclonal Antibody Custom Service Market
    85. Competitive
    86. Benchmarking
    87. Leading Players in Terms of Number of Developments
    88. in the Monoclonal Antibody Custom Service Market
    89. Key
    90. developments and growth strategies
    91. New Product Launch/Service
    92. Deployment
    93. Merger & Acquisitions
    94. Joint
    95. Ventures
    96. Major Players Financial Matrix
    97. Sales
    98. and Operating Income
    99. Major Players R&D Expenditure.
    100. Company
    101. Profiles
    102. Tigermed
    103. Financial
    104. Overview
    105. Products Offered
    106. Key
    107. Developments
    108. SWOT Analysis
    109. Key
    110. Strategies
    111. Abcam
    112. Financial
    113. Overview
    114. Products Offered
    115. Key
    116. Developments
    117. SWOT Analysis
    118. Key
    119. Strategies
    120. BioRad
    121. Financial
    122. Overview
    123. Products Offered
    124. Key
    125. Developments
    126. SWOT Analysis
    127. Key
    128. Strategies
    129. Genscript
    130. Financial
    131. Overview
    132. Products Offered
    133. Key
    134. Developments
    135. SWOT Analysis
    136. Key
    137. Strategies
    138. MedChemExpress
    139. Financial
    140. Overview
    141. Products Offered
    142. Key
    143. Developments
    144. SWOT Analysis
    145. Key
    146. Strategies
    147. Novoprotein
    148. Financial
    149. Overview
    150. Products Offered
    151. Key
    152. Developments
    153. SWOT Analysis
    154. Key
    155. Strategies
    156. GenScript Biotech
    157. Financial
    158. Overview
    159. Products Offered
    160. Key
    161. Developments
    162. SWOT Analysis
    163. Key
    164. Strategies
    165. Sino Biological
    166. Financial
    167. Overview
    168. Products Offered
    169. Key
    170. Developments
    171. SWOT Analysis
    172. Key
    173. Strategies
    174. WuXi AppTec
    175. Financial
    176. Overview
    177. Products Offered
    178. Key
    179. Developments
    180. SWOT Analysis
    181. Key
    182. Strategies
    183. HengRui Medicine
    184. Financial
    185. Overview
    186. Products Offered
    187. Key
    188. Developments
    189. SWOT Analysis
    190. Key
    191. Strategies
    192. Thermo Fisher Scientific
    193. Financial
    194. Overview
    195. Products Offered
    196. Key
    197. Developments
    198. SWOT Analysis
    199. Key
    200. Strategies
    201. Cell Signaling Technology
    202. Financial
    203. Overview
    204. Products Offered
    205. Key
    206. Developments
    207. SWOT Analysis
    208. Key
    209. Strategies
    210. KeyGen Biotech
    211. Financial
    212. Overview
    213. Products Offered
    214. Key
    215. Developments
    216. SWOT Analysis
    217. Key
    218. Strategies
    219. Fapon Biotech
    220. Financial
    221. Overview
    222. Products Offered
    223. Key
    224. Developments
    225. SWOT Analysis
    226. Key
    227. Strategies
    228. Eureka Therapeutics
    229. Financial
    230. Overview
    231. Products Offered
    232. Key
    233. Developments
    234. SWOT Analysis
    235. Key
    236. Strategies
    237. References
    238. Related
    239. Reports
    240. LIST
    241. OF ASSUMPTIONS
    242. China Monoclonal Antibody Custom Service
    243. Market SIZE ESTIMATES & FORECAST, BY TYPE, 2019-2035 (USD Billions)
    244. China
    245. Monoclonal Antibody Custom Service Market SIZE ESTIMATES & FORECAST, BY APPLICATION,
    246. 2035 (USD Billions)
    247. China Monoclonal Antibody Custom
    248. Service Market SIZE ESTIMATES & FORECAST, BY END USER, 2019-2035 (USD Billions)
    249. PRODUCT
    250. LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
    251. ACQUISITION/PARTNERSHIP
    252. LIST
    253. Of figures
    254. MARKET SYNOPSIS
    255. CHINA
    256. MONOCLONAL ANTIBODY CUSTOM SERVICE MARKET ANALYSIS BY TYPE
    257. CHINA
    258. MONOCLONAL ANTIBODY CUSTOM SERVICE MARKET ANALYSIS BY APPLICATION
    259. CHINA
    260. MONOCLONAL ANTIBODY CUSTOM SERVICE MARKET ANALYSIS BY END USER
    261. KEY
    262. BUYING CRITERIA OF MONOCLONAL ANTIBODY CUSTOM SERVICE MARKET
    263. RESEARCH
    264. PROCESS OF MRFR
    265. DRO ANALYSIS OF MONOCLONAL ANTIBODY CUSTOM
    266. SERVICE MARKET
    267. DRIVERS IMPACT ANALYSIS: MONOCLONAL ANTIBODY
    268. CUSTOM SERVICE MARKET
    269. RESTRAINTS IMPACT ANALYSIS: MONOCLONAL
    270. ANTIBODY CUSTOM SERVICE MARKET
    271. SUPPLY / VALUE CHAIN:
    272. MONOCLONAL ANTIBODY CUSTOM SERVICE MARKET
    273. MONOCLONAL
    274. ANTIBODY CUSTOM SERVICE MARKET, BY TYPE, 2025 (% SHARE)
    275. MONOCLONAL
    276. ANTIBODY CUSTOM SERVICE MARKET, BY TYPE, 2019 TO 2035 (USD Billions)
    277. MONOCLONAL
    278. ANTIBODY CUSTOM SERVICE MARKET, BY APPLICATION, 2025 (% SHARE)
    279. MONOCLONAL
    280. ANTIBODY CUSTOM SERVICE MARKET, BY APPLICATION, 2019 TO 2035 (USD Billions)
    281. MONOCLONAL
    282. ANTIBODY CUSTOM SERVICE MARKET, BY END USER, 2025 (% SHARE)
    283. MONOCLONAL
    284. ANTIBODY CUSTOM SERVICE MARKET, BY END USER, 2019 TO 2035 (USD Billions)
    285. BENCHMARKING
    286. OF MAJOR COMPETITORS

    China Monoclonal Antibody Custom Service Market Segmentation

    • Monoclonal Antibody Custom Service Market By Type (USD Million, 2019-2035)

      • Rat Custom Monoclonal Antibody
      • Rabbit Custom Monoclonal Antibody
    • Monoclonal Antibody Custom Service Market By Application (USD Million, 2019-2035)

      • Diagnostic Application (Biochemical Analysis (Pregnancy Cancer Hormonal Disorder And Infectious Diseases)
      • Diagnostic Imaging (Cardiovascular Diseases, Cancer and Bacterial Infections)
      • Therapeutic Application (MAb as Therapeutic Agents and MAb as Targeting Agents)
      • Protein Purification
    • Monoclonal Antibody Custom Service Market By End User (USD Million, 2019-2035)

      • Hospitals
      • Research
    Report Infographic
    Free Sample Request

    Kindly complete the form below to receive a free sample of this Report

    Customer Strories

    “I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

    Victoria Milne Founder
    Case Study

    Chemicals and Materials